Cargando…

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity

BACKGROUND: A core feature of chronic obstructive pulmonary disease (COPD) is the accelerated decline in forced expiratory volume in one second (FEV(1)). The recent Groningen and Leiden Universities study of Corticosteroids in Obstructive Lung Disease (GLUCOLD) study suggested that particular phenot...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Berge, Maarten, Steiling, Katrina, Timens, Wim, Hiemstra, Pieter S, Sterk, Peter J, Heijink, Irene H, Liu, Gang, Alekseyev, Yuriy O, Lenburg, Marc E, Spira, Avrum, Postma, Dirkje S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888587/ https://www.ncbi.nlm.nih.gov/pubmed/23925644 http://dx.doi.org/10.1136/thoraxjnl-2012-202878

Ejemplares similares

Th2 high and mast cell gene signatures are associated with corticosteroid sensitivity in COPD
por: Faiz, Alen, et al.
Publicado: (2023)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial
por: Harries, Timothy H, et al.
Publicado: (2022)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease
por: Eklöf, Josefin, et al.
Publicado: (2022)

Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
por: Bowler, Russell, et al.
Publicado: (2019)

Estimating individual treatment effects on COPD exacerbations by causal machine learning on randomised controlled trials
por: Verstraete, Kenneth, et al.
Publicado: (2023)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England
por: Czira, Alexandrosz, et al.
Publicado: (2022)

Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study
por: Citgez, Emanuel, et al.
Publicado: (2016)

Systemic inflammation induced by exacerbation of COPD or pneumonia in patients with COPD induces cardiac troponin elevation
por: Søyseth, Vidar, et al.
Publicado: (2021)

Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence
por: Farias, Raquel, et al.
Publicado: (2019)

Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
por: Parkin, Lianne, et al.
Publicado: (2021)

Are clinical risk scores for COPD useful?
por: Quint, Jennifer K
Publicado: (2015)

Specialist emergency care and COPD outcomes
por: Lane, Nicholas David, et al.
Publicado: (2018)

Increased expression of placenta growth factor in COPD
por: Cheng, S-L, et al.
Publicado: (2008)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Angiopoietin-like protein 4 and cardiovascular function in COPD
por: Waschki, B, et al.
Publicado: (2016)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Identifying the challenges and facilitators of implementing a COPD care bundle
por: Lennox, Laura, et al.
Publicado: (2014)

Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes
por: Fortis, Spyridon, et al.
Publicado: (2017)

No association between DNA methylation and COPD in never and current smokers
por: de Vries, Maaike, et al.
Publicado: (2018)

Reducing hospital admissions for COPD: perspectives following the Christchurch Earthquake
por: Epton, Michael, et al.
Publicado: (2018)

ACE and response to pulmonary rehabilitation in COPD: two observational studies
por: Kon, Samantha S C, et al.
Publicado: (2017)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Physical and affective components of dyspnoea are improved by pulmonary rehabilitation in COPD
por: Grosbois, Jean-Marie, et al.
Publicado: (2022)

Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD
por: Garratt, Andrew Malcolm, et al.
Publicado: (2022)

Determinants and outcomes of physical activity in patients with COPD: a systematic review
por: Gimeno-Santos, Elena, et al.
Publicado: (2014)

Increased skeletal muscle-specific microRNA in the blood of patients with COPD
por: Donaldson, Anna, et al.
Publicado: (2013)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
por: Echevarria, C, et al.
Publicado: (2016)

Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD
por: Steer, John, et al.
Publicado: (2015)

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD
por: Boutou, Afroditi K, et al.
Publicado: (2014)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
por: Maddocks, Matthew, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rc87plql0eiuminjfoon1h1ke4